CTMX (CTMX) Stock Price & Analysis
CTMX (CTMX) rose 0.81% to USD 3.71 as of September 8, 2026 at 06:22 UTC, according to Nexqual real-time market data.
CTMX last closed at USD 3.71; the session ranged USD 3.53–3.73 on volume of 2,297,761 shares. Market capitalization is —, with a 52-week range of USD 1.9–8.21 (NMS). Source: Nexqual, September 8, 2026 at 06:22 UTC.
Key Statistics (as of September 8, 2026 at 06:22 UTC)
| Price | USD 3.71 |
|---|---|
| Change | ▲ 0.81% (up) |
| Previous Close | USD 3.71 |
| Open | USD 3.71 |
| Day Range | USD 3.53 – 3.73 |
| 52-Week Range | USD 1.9 – 8.21 |
| Volume | 2,297,761 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (CTMX)
Nexqual's technical model rates CTMX "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:22 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.27 (neutral) |
| vs SMA50 | Above (USD 3.48) |
| MACD | 0.06 (positive) |
From CTMX's Latest SEC 10-K Filing (filed 2026-03-16)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MGNX | MacroGenics, Inc. | USD 4.4 | ▲ 1.85% |
| KALA | KALA BIO, Inc. | USD 0.51 | ▼ 3.06% |
| ASMB | Assembly Biosciences, Inc. | USD 36.6 | ▼ 0.33% |
| CRVS | Corvus Pharmaceuticals, Inc. | USD 14.39 | ▲ 1.34% |
| ATRA | Atara Biotherapeutics, Inc. | USD 9.76 | ▲ 3.39% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:22 UTC. This page is informational and not investment advice.